Abstract
The usage of synthetic medicine produced through chemical synthesis shows health hazards and eco-toxicological effects; hence, much attention is paid on the field of bioactive compounds which are efficient with eco-friendly nature. Rhamnolipids biosurfactant in medical field is in trial stage, but most of the experimental results prove very effective due to their safe nature as compared to synthetic medicines. They have been reported for its anti-inflammatory, anticarcinogenic, immune-modulator, anti-microbial, and antitumor activities. Hence, the present chapter represents and describes rhamnolipid biosurfactant as a potential therapeutic agent in biomedical field.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abalos A, Pinazo A, Infante MR, Casals M, Garcia F, Manresa A (2001) Physicochemical and antimicrobial properties of new rhamnolipids produced by Pseudomonas a eruginosa AT10 from soybean oil refinery wastes. Langmuir 17(5):1367–1371
Banat IM, Franzetti A, Gandolfi I, Bestetti G, Martinotti MG, Fracchia L et al (2010) Microbial biosurfactants production, applications and future potential. Appl Microbiol Biotechnol 80:427–444
Banat IM, De Rienzo MAD, Quinn GA (2014) Microbial biofilms: biosurfactants as antibiofilm agents. Appl Microbiol Biotechnol 98(24):9915–9929
Boles BR, Thoendel M, Singh PK (2005) Rhamnolipids mediate detachment of Pseudomonas aeruginosa from biofilms. Mol Microbiol 57(5):1210–1223. https://doi.org/10.1111/j.1365-2958.2005.04743.x PMID 16101996
Cameotra SS, Makkar RS (2004) Recent applications of biosurfactants as biological and immunological molecules. Curr Opin Microbiol 7(3):262–266
Christova N, Tuleva B, Kril A, Georgieva M, Konstantinov S, Terziyski I, Stoineva I (2013) Chemical structure and in vitro antitumor activity of rhamnolipids from Pseudomonas aeruginosa BN10. Appl Biochem Biotechnol 170(3):676–689
Davey ME, Caiazza NC, O’Toole GA (2003) Rhamnolipid surfactant production affects biofilm architecture in Pseudomonas aeruginosa PAO1. J Bacteriol 185(3):1027–1036
do Valle Gomes MZ, Nitschke M (2012) Evaluation of rhamnolipid and surfactin to reduce the adhesion and remove biofilms of individual and mixed cultures of food pathogenic bacteria. Food Control 25(2):441–447
Donlan RM (2002) Biofilms: microbial life on surfaces. Emerg Infect Dis 8(9):881
Duarte C, Gudiña EJ, Lima CF, Rodrigues LR (2014) Effects of biosurfactants on the viability and proliferation of human breast cancer cells. AMB Express 4(1):40
Dusane DH, Nancharaiah YV, Zinjarde SS, Venugopalan VP (2010) Rhamnolipid mediated disruption of marine Bacillus pumilus biofilms. Colloids Surf B Biointerfaces 81:242–248
Glick R, Gilmour C, Tremblay J, Satanower S, Avidan O, Déziel E, Greenberg EP, Poole K, Banin E (2010) Increase in rhamnolipid synthesis under iron-limiting conditions influences surface motility and biofilm formation in Pseudomonas aeruginosa. J Bacteriol 192(12):2973–2980. https://doi.org/10.1128/JB.01601-09 PMC 2901684 . PMID 20154129
Hajfarajollah H, Mehvari S, Habibian M, Mokhtarani B, Noghabi KA (2015) Rhamnolipid biosurfactant adsorption on a plasma-treated polypropylene surface to induce antimicrobial and antiadhesive properties. RSC Adv 5(42):33089–33097
Hall-Stoodley L, Stoodley P (2002) Developmental regulation of microbial biofilms. Curr Opin Biotechnol 13:228–233
Irfan-Maqsood M, Seddiq-Shams M (2014) Rhamnolipids: well-characterized glycolipids with potential broad applicability as biosurfactants. Ind Biotechnol 10(4):285–291
Irie Y, O’Toole GA, Yuk MH (2005) Pseudomonas aeruginosa rhamnolipids disperse Bordetella bronchiseptica biofilms. FEMS Microbiol Lett 250:237–243
Ivanova A, Karpenko E, Galabov AS, Remichkova M (2010) Effect of Pseudomonas sp. S-17 rhamnolipid on herpes simplex virus type 2. C R Acad Bulg Sci 64(1):157–160
de Jesus Cortes-Sanchez A, Hernández-Sánchez H, Jaramillo-Flores ME (2013) Biological activity of glycolipids produced by microorganisms: new trends and possible therapeutic alternatives. Microbiol Res 168(1):22–32
Kamal A, Shaik AB, Kumar CG, Mongolla P, Rani PU, Krishna KV, Joseph J (2012) Metabolic profiling and biological activities of bioactive compounds produced by Pseudomonas sp. strain ICTB-745 isolated from Ladakh, India. J Microbiol Biotechnol 22(1):69–79
Katariya HB (2012) The concept of microbubble as a drug delivery system: an overview. Int J Pharm Sci Res 3(9):3058
Kosaric N (1993) Biosurfactants: production, properties, applications. CRC Press, Boca Raton, p 48
McClure CD, Schiller NL (1992) Effects of Pseudomonas aeruginosa rhamnolipids on human monocyte-derived macrophages. J Leukoc Biol 51(2):97–102
Murray TS, Kazmierczak BI (2008) Pseudomonas aeruginosa exhibits sliding motility in the absence of type IV pili and flagella. J Bacteriol 190(8):2700–2708
Nguyen TT, Sabatini DA (2011) Characterization and emulsification properties of rhamnolipid and sophorolipid biosurfactants and their applications. Int J Mol Sci 12:1232–1244
Ortiz A, Teruel JA, Espuny MJ, Marqués A, Manresa Á, Aranda FJ (2006) Effects of dirhamnolipid on the structural properties of phosphatidylcholine membranes. Int J Pharm 325(1):99–107
Pamp SJ, Tolker-Nielsen T (2007) Multiple roles of biosurfactants in structural biofilm development by Pseudomonas aeruginosa. J Bacteriol 189(6):2531–2539
Remichkova M, Galabova D, Roeva I, Karpenko E, Shulga A, Galabov AS (2008) Anti-herpesvirus activities of Pseudomonas sp. S-17 rhamnolipid and its complex with alginate. Z Naturforsch C 63(1–2):75–81
Rodrigues L, Banat IM, Teixeira J, Oliveir R (2006) Biosurfactants: potential applications in medicine. J Antimicrob Chemother 57:609–618
Sagar SS, Kumar R, Kaistha SD (2016) Biofilm-an eternalchronicle of bacteria. Indian J Comp Microbiol Immunol Infect Dis 37(2):45–56
Sharma D (2016) Biosurfactants in food. Springer, Cham
Shen C, Jiang L, Shao H, You C, Zhang G, Ding S, Meng Q (2016) Targeted killing of myofibroblasts by biosurfactant di-rhamnolipid suggests a therapy against scar formation. Sci Rep 6:37553
Shrivastava SR, Shrivastava PS, Ramasamy J (2014) Occupational cancer: public health interventions to minimize its burden and impact on the society. Iran J Cancer Prev 7(2):111
Stipcevic T, Piljac A, Piljac G (2006) Enhanced healing of full-thickness burn wounds using di-rhamnolipid. Burns 32(1):24–34
Thanomsub B, Pumeechockchai W, Limtrakul A, Arunrattiyakorn P, Petchleelaha W, Nitoda T, Kanzaki H (2006) Chemical structures and biological activities of rhamnolipids produced by Pseudomonas aeruginosa B189 isolated from milk factory waste. Bioresour Technol 97(18):2457–2461
Wittschier N, Lengsfeld C, Vorthems S, Stratmann U, Ernst JF, Verspohl EJ, Hensel A (2007) Large molecules as anti-adhesive compounds against pathogens. J Pharm Pharmacol 59(6):777–786
Xu Q, Nakajima M, Liu Z, Shiina T (2011) Biosurfactants for microbubble preparation and application. Int J Mol Sci 12(1):462–475
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Kumar, R., Das, A.J. (2018). Application of Rhamnolipids in Medical Sciences. In: Rhamnolipid Biosurfactant. Springer, Singapore. https://doi.org/10.1007/978-981-13-1289-2_7
Download citation
DOI: https://doi.org/10.1007/978-981-13-1289-2_7
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-13-1288-5
Online ISBN: 978-981-13-1289-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)
